C.-W. Chi

866 total citations
31 papers, 705 citations indexed

About

C.-W. Chi is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, C.-W. Chi has authored 31 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pharmacology. Recurrent topics in C.-W. Chi's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Estrogen and related hormone effects (5 papers) and Cancer, Lipids, and Metabolism (4 papers). C.-W. Chi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Estrogen and related hormone effects (5 papers) and Cancer, Lipids, and Metabolism (4 papers). C.-W. Chi collaborates with scholars based in Taiwan, China and Czechia. C.-W. Chi's co-authors include W Y Lui, F.I. Chou, Hsien‐Li Kao, Shin‐Da Lee, Hong Chen, Shang‐Lun Chiang, Teh‐Ia Huo, Cheng‐Yuan Hsia, J.‐C. Wu and Wing‐Yee Lui and has published in prestigious journals such as The FASEB Journal, Journal of Allergy and Clinical Immunology and Cellular and Molecular Life Sciences.

In The Last Decade

C.-W. Chi

31 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.-W. Chi Taiwan 17 240 108 108 83 76 31 705
Orazia M. Granata Italy 19 234 1.0× 39 0.4× 96 0.9× 164 2.0× 52 0.7× 40 962
Sebastián D. Calligaris Chile 14 433 1.8× 45 0.4× 92 0.9× 40 0.5× 112 1.5× 23 831
Yuqin Wang China 16 385 1.6× 35 0.3× 108 1.0× 46 0.6× 89 1.2× 26 663
Yoshiki Amuro Japan 17 341 1.4× 91 0.8× 87 0.8× 222 2.7× 108 1.4× 52 735
Kouji Watanabe Japan 14 279 1.2× 51 0.5× 197 1.8× 190 2.3× 45 0.6× 51 1.3k
Wafaey Gomaa Saudi Arabia 14 192 0.8× 39 0.4× 61 0.6× 179 2.2× 55 0.7× 47 618
Guoguo Shang China 10 275 1.1× 31 0.3× 71 0.7× 88 1.1× 49 0.6× 15 496
Huilai Miao China 16 428 1.8× 45 0.4× 180 1.7× 139 1.7× 127 1.7× 36 771
Emilio Siendones Spain 17 364 1.5× 40 0.4× 72 0.7× 37 0.4× 44 0.6× 22 891
Tatsuo Katagishi Japan 12 234 1.0× 306 2.8× 104 1.0× 145 1.7× 275 3.6× 16 952

Countries citing papers authored by C.-W. Chi

Since Specialization
Citations

This map shows the geographic impact of C.-W. Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.-W. Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.-W. Chi more than expected).

Fields of papers citing papers by C.-W. Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.-W. Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.-W. Chi. The network helps show where C.-W. Chi may publish in the future.

Co-authorship network of co-authors of C.-W. Chi

This figure shows the co-authorship network connecting the top 25 collaborators of C.-W. Chi. A scholar is included among the top collaborators of C.-W. Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.-W. Chi. C.-W. Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Qiqiao, Yili Chen, Xiaojun Wang, et al.. (2025). Galectin-3 suppresses CD8+ T cells function via myeloid-derived suppressor cells recruitment in cervical cancer. International Journal of Biological Macromolecules. 311(Pt 4). 143683–143683. 2 indexed citations
2.
Chen, Yili, et al.. (2025). Cuproptosis inhibits tumor progression and enhances cisplatin toxicity in ovarian cancer. The FASEB Journal. 39(6). e70484–e70484. 2 indexed citations
3.
Gong, Wenbin, Yi Su, Dantong Sun, et al.. (2018). Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma. Neoplasma. 65(3). 326–330. 19 indexed citations
4.
5.
Chou, F.I., et al.. (2009). Suitability of boron carriers for BNCT: Accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. Applied Radiation and Isotopes. 67(7-8). S105–S108. 38 indexed citations
6.
Chang, Chih‐Jung, Peiqi Yin, De‐Ming Yang, et al.. (2009). Mitochondrial dysfunction-induced amphiregulin upregulation mediates chemo-resistance and cell migration in HepG2 cells. Cellular and Molecular Life Sciences. 66(10). 1755–1765. 42 indexed citations
7.
Chung, Yoo Seung, et al.. (2008). Safrole-DNA adduct in hepatocellular carcinoma associated with betel quid chewing. Toxicology Letters. 183(1-3). 21–27. 31 indexed citations
8.
Lin, Jin‐Ching, Chew Wun Wu, Ling‐Ming Tseng, et al.. (2008). Tandem duplication/triplication correlated with poly-cytosine stretch variation in human mitochondrial DNA D-loop region. Mutagenesis. 23(2). 137–142. 25 indexed citations
9.
Chau, G Y, et al.. (2007). Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection. European Journal of Surgical Oncology. 34(3). 333–338. 34 indexed citations
10.
Lin, Angela, Pei‐Ling Chao, Shengyun Fang, C.-W. Chi, & James Chih‐Hsin Yang. (2007). Endoplasmic reticulum stress is involved in arsenite-induced oxidative injury in rat brain. Toxicology and Applied Pharmacology. 224(2). 138–146. 37 indexed citations
11.
Hsia, Cheng‐Yuan, Teh‐Ia Huo, Shang‐Lun Chiang, et al.. (2006). Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. European Journal of Surgical Oncology. 33(2). 208–212. 102 indexed citations
12.
Chi, C.-W., et al.. (2005). Cholinesterase Inhibitor Affects the Amyloid Precursor Protein Isoforms in Patients with Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 19(5-6). 345–348. 13 indexed citations
13.
14.
Liu, Tzu‐Yu, et al.. (2004). Estrogen-Metabolizing Gene COMT Polymorphism Synergistic APOE ε4 Allele Increases the Risk of Alzheimer Disease. Dementia and Geriatric Cognitive Disorders. 19(2-3). 120–125. 29 indexed citations
15.
Tseng, Ling‐Ming, et al.. (2004). Polymorphism of estrogen metabolism genes and cataract. Medical Hypotheses. 63(3). 494–497. 6 indexed citations
16.
Lui, Wing‐Yee, et al.. (2000). Male predominance in hepatocellular carcinoma: new insight and a possible therapeutic alternative. Medical Hypotheses. 55(4). 348–350. 13 indexed citations
17.
Chou, F.I., Kang Fang, Cheng‐Yu Chung, et al.. (1995). Lipiodol uptake and retention by human hepatoma cells. Nuclear Medicine and Biology. 22(3). 379–386. 27 indexed citations
18.
Han, S H, et al.. (1993). Use of monoclonal antibodies to isolate and characterize Cyn dI, the major allergen of Bermuda grass pollen. Journal of Allergy and Clinical Immunology. 92(4). 549–558. 31 indexed citations
19.
Han, Shou‐Hwa, Zhidong Chang, Hung-Chun Chang, et al.. (1993). Identification and characterization of epitopes on Cyn d I, the major allergen of Bermuda grass pollen. Journal of Allergy and Clinical Immunology. 91(5). 1035–1041. 10 indexed citations
20.
Lui, W Y, et al.. (1991). Hormonal therapy for hepatocellular carcinoma. Medical Hypotheses. 36(2). 162–165. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orazia M. Granata Breakdown of academic impact, for papers by Sebastián D. Calligaris Breakdown of academic impact, for papers by Yuqin Wang Breakdown of academic impact, for papers by Yoshiki Amuro Breakdown of academic impact, for papers by Kouji Watanabe Breakdown of academic impact, for papers by Wafaey Gomaa Breakdown of academic impact, for papers by Guoguo Shang Breakdown of academic impact, for papers by Huilai Miao Breakdown of academic impact, for papers by Emilio Siendones Breakdown of academic impact, for papers by Tatsuo Katagishi
Rankless by CCL
2026